• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性失代偿和慢加急性肝衰竭

Acute Decompensation and Acute-on-Chronic Liver Failure.

作者信息

Ferstl Philip, Trebicka Jonel

机构信息

Department for Internal Medicine I, University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany.

Department for Internal Medicine I, University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany; European Foundation for the Study of Chronic Liver Failure, Travesera de Gracia 11, 08021 Barcelona, Spain.

出版信息

Clin Liver Dis. 2021 May;25(2):419-430. doi: 10.1016/j.cld.2021.01.009. Epub 2021 Mar 10.

DOI:10.1016/j.cld.2021.01.009
PMID:33838858
Abstract

Liver cirrhosis is a major healthcare problem. Acute decompensation, and in particular its interplay with dysfunction of other organs, is responsible for the majority of deaths in patients with cirrhosis. Acute decompensation has different courses, from stable decompensated cirrhosis over unstable decompensated cirrhosis to pre-acute-on-chronic liver failure and finally acute-on-chronic liver failure, a syndrome with high short-term mortality. This review focuses on the recent developments in the field of acute decompensation and acute-on-chronic liver failure.

摘要

肝硬化是一个重大的医疗保健问题。急性失代偿,尤其是其与其他器官功能障碍的相互作用,是肝硬化患者死亡的主要原因。急性失代偿有不同的病程,从稳定的失代偿性肝硬化到不稳定的失代偿性肝硬化,再到慢性肝衰竭急性发作前期,最终发展为慢性肝衰竭急性发作,这是一种短期死亡率很高的综合征。本综述重点关注急性失代偿和慢性肝衰竭急性发作领域的最新进展。

相似文献

1
Acute Decompensation and Acute-on-Chronic Liver Failure.急性失代偿和慢加急性肝衰竭
Clin Liver Dis. 2021 May;25(2):419-430. doi: 10.1016/j.cld.2021.01.009. Epub 2021 Mar 10.
2
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.近期在代偿期肝硬化和慢加急性肝衰竭(ACLF)的预防和治疗方面的进展,以及生物标志物的作用。
Gut. 2024 May 10;73(6):1015-1024. doi: 10.1136/gutjnl-2023-330584.
3
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.代偿期和失代偿期肝硬化患者的死亡预测因素:细菌感染及感染相关慢加急性肝衰竭的作用
Scand J Gastroenterol. 2015 Jul;50(7):875-83. doi: 10.3109/00365521.2015.1017834. Epub 2015 Feb 19.
4
Novel drug discovery strategies for the treatment of decompensated cirrhosis.用于治疗失代偿性肝硬化的新型药物发现策略。
Expert Opin Drug Discov. 2022 Mar;17(3):273-282. doi: 10.1080/17460441.2022.2020755. Epub 2021 Dec 31.
5
The Clinical Spectrum and Manifestations of Acute-on-Chronic Liver Failure.慢性肝衰竭的临床谱和表现。
Clin Liver Dis. 2023 Aug;27(3):671-680. doi: 10.1016/j.cld.2023.03.010. Epub 2023 Apr 23.
6
The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis.系统性炎症假说:走向肝硬化急性失代偿和多器官衰竭的新范式。
J Hepatol. 2021 Mar;74(3):670-685. doi: 10.1016/j.jhep.2020.11.048. Epub 2020 Dec 7.
7
The microbiota in cirrhosis and its role in hepatic decompensation.肝硬化中的微生物群及其在肝性失代偿中的作用。
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S67-S81. doi: 10.1016/j.jhep.2020.11.013.
8
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure.急性肝衰竭向慢性肝衰竭的发病机制和治疗方法。
Am J Physiol Cell Physiol. 2023 Jul 1;325(1):C129-C140. doi: 10.1152/ajpcell.00101.2023. Epub 2023 Jun 5.
9
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
10
Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?肝硬化患者的细菌感染是失代偿的原因还是后果?
Clin Liver Dis. 2021 May;25(2):357-372. doi: 10.1016/j.cld.2021.01.006. Epub 2021 Mar 10.

引用本文的文献

1
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.基于机器学习的HBV-ACLF细菌感染诊断模型的构建与验证
BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5.
2
Geriatric Nutritional Risk Index as a Predictor of Overall Survival in Cirrhosis: A Retrospective Cohort Study.老年营养风险指数作为肝硬化患者总生存期的预测指标:一项回顾性队列研究
Curr Med Sci. 2025 May 7. doi: 10.1007/s11596-025-00056-w.
3
Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol-associated liver disease.
既往代谢和减重手术是酒精性肝病失代偿严重程度的独立决定因素。
United European Gastroenterol J. 2024 Dec;12(10):1440-1449. doi: 10.1002/ueg2.12642. Epub 2024 Nov 15.
4
Road to recompensation: Baveno VII criteria and transjugular intrahepatic portosystemic shunt in liver cirrhosis.肝硬化的再补偿之路:Baveno VII 标准与经颈静脉肝内门体分流术。
World J Gastroenterol. 2024 Aug 28;30(32):3743-3747. doi: 10.3748/wjg.v30.i32.3743.
5
Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit.开发和验证 ICU 中慢加急性肝衰竭患者的新预后模型。
World J Gastroenterol. 2024 May 28;30(20):2657-2676. doi: 10.3748/wjg.v30.i20.2657.
6
Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort study.慢性肝病急性发作的特征:一项多中心前瞻性队列研究。
World J Hepatol. 2024 May 27;16(5):809-821. doi: 10.4254/wjh.v16.i5.809.
7
Uridine diphosphate glucuronosyltransferase 1A1 prevents the progression of liver injury.尿苷二磷酸葡萄糖醛酸基转移酶 1A1 可阻止肝损伤的进展。
World J Gastroenterol. 2024 Mar 7;30(9):1189-1212. doi: 10.3748/wjg.v30.i9.1189.
8
Acute and non-acute decompensation of liver cirrhosis (47/130).肝硬化的急性和非急性失代偿(47/130)
Liver Int. 2025 Mar;45(3):e15861. doi: 10.1111/liv.15861. Epub 2024 Mar 1.
9
Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases.揭示火焰:巨噬细胞焦亡及其在肝脏疾病中的关键作用。
Front Immunol. 2024 Feb 6;15:1338125. doi: 10.3389/fimmu.2024.1338125. eCollection 2024.
10
Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives.肝硬化及其并发症的预后评估:当前概念与未来展望
Front Med (Lausanne). 2023 Sep 14;10:1268102. doi: 10.3389/fmed.2023.1268102. eCollection 2023.